CD_NAME : CD1b

    DESC: CD1B antigen; b polypeptide
    M-T101 IgG1  Rieber  BD Biosciences
    SN13 IgG1  Seon  eBioscience
    M-T101 IgG1  Rieber  AbD Serotec
    4A7.6 IgG2a  Mawas 
    7C4 unknown  Knapp 
    100-1A5 IgM  Vilella 
    F111-132 IgG1  Carriere 
    F111-342 IgG1  Carriere 
    F111-495 IgG1  Carriere 
    M-T101 IgG1  Rieber  BD Biosciences
    NU-T2 IgG1  Sagawa 
    O249 IgG1  Boumsell 
    SN13 IgG1  Seon  eBioscience
    WM25 IgG1  Bradstock 
    M-T101 IgG1  Rieber  AbD Serotec

    CD1b is a non-polymorphic type 1 integral glycoprotein with a similar structure to MHC class I molecules. CD1b is composed of a short cytoplasmic tail, a transmembrane domain and an extracellular region that contains 3 α domains.1-2 The α1 and α2 domains bind to the ligand.2 The α3 domain interacts with β-2 microglobulin forming a heterodimer. 2 The cytoplasmatic tail contains a tyrosine-based motif for adaptors binding. 2                                

    1. Kaczmarek R, Pasciak M, Szymczak-Kulus K, Czerwinski M. CD1: A Singed Cat of the Three Antigen Presentation Systems. Arch Immunol Ther Exp (Warsz). 2017;65:201-214.
    2. Zajonc DM. The CD1 family: serving lipid antigens to T cells since the Mesozoic era. Immunogenetics. 2016;68:561-76.


    CD1b can bind to mycolic acid1, sulfoglycolipids2, lipoarabinomannan3, phosphatidylinositol mannosides4, gangliosides5-6, phosphatidylcholine7, glycerol monomycolate8, glucose monomycolate9 and TCR10. It interacts with β-2 microglobulin in cis.11

    Intracellular associate molecules

    CD1b can be associated with AP-3, AP-2 and saposin C (in lysosomes).12-14

    1. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature. 1994;372:691-4.
    2. Guiard J, Collmann A, Garcia-Alles LF, Mourey L, Brando T, Mori L, Gilleron M, Prandi J, De Libero G, Puzo G. Fatty acyl structures of mycobacterium tuberculosis sulfoglycolipid govern T cell response. J Immunol. 2009;182:7030-7.
    3. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJ, et al. CD1-restricted T   cell  recognition of microbial lipoglycan antigens. Science. 1995;269:227-30.
    4. de la Salle H, Mariotti S, Angenieux C, Gilleron M, Garcia-Alles LF, Malm D, Berg T, Paoletti S, Maître B, Mourey L, Salamero J, Cazenave JP, Hanau D, Mori L, Puzo G, De Libero G. Assistance of microbial glycolipid antigen processing by CD1e. Science. 2005;310:1321-4.
    5. Shamshiev A, Donda A, Prigozy TI, Mori L, Chigorno V, Benedict CA, Kappos L, Sonnino S, Kronenberg M, De Libero G. The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity. 2000;13:255-64.
    6. Gadola SD, Zaccai NR, Harlos K, Shepherd D, Castro-Palomino JC, Ritter G, Schmidt RR, Jones EY, Cerundolo V. Structure of human CD1b with bound ligands at  2.3 A, a maze for alkyl chains. Nat Immunol. 2002;3:721-6.
    7. Garcia-Alles LF, Versluis K, Maveyraud L, Vallina AT, Sansano S, Bello NF, Gober HJ, Guillet V, de la Salle H, Puzo G, Mori L, Heck AJ, De Libero G, Mourey L. Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. EMBO J. 2006;25:3684-92.
    8. Layre E, Collmann A, Bastian M, Mariotti S, Czaplicki J, Prandi J, Mori L, Stenger S, De Libero G, Puzo G, Gilleron M. Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells. Chem Biol. 2009;16:82-92.
    9. Moody DB, Reinhold BB, Guy MR, Beckman EM, Frederique DE, Furlong ST, Ye S,Reinhold VN, Sieling PA, Modlin RL, Besra GS, Porcelli SA. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science. 1997;278:283-6.
    10. Gras S, Van Rhijn I, Shahine A, Cheng TY, Bhati M, Tan LL, Halim H, Tuttle KD, Gapin L, Le Nours J, Moody DB, Rossjohn J. T cell receptor recognition of CD1b presenting a mycobacterial glycolipid. Nat Commun. 2016;7:13257.
    11. Zajonc DM. The CD1 family: serving lipid antigens to T cells since the Mesozoic era. Immunogenetics. 2016;68:561-76.
    12. Sugita M, Cao X, Watts GF, Rogers RA, Bonifacino JS, Brenner MB. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity. 2002;16:697-706.
    13. Van Rhijn I, Ly D, Moody DB. CD1a, CD1b, and CD1c in immunity against mycobacteria. Adv Exp Med Biol. 2013;783:181-97.
    14. Winau F, Schwierzeck V, Hurwitz R, Remmel N, Sieling PA, Modlin RL, Porcelli SA, Brinkmann V, Sugita M, Sandhoff K, Kaufmann SH, Schaible UE. Saposin C is required for lipid presentation by human CD1b. Nat Immunol. 2004;5:169-74.


    CD_NAME : CD1b

    As other members of the CD1 family, CD1b is expressed on thymocytes.1 Furthermore, it is also expressed on dendritic cells including interdigitating and dermal dendritic cells.2

    1. Reinink P, Van Rhijn I. Mammalian CD1 and MR1 genes. Immunogenetics. 2016;68:515-23.
    2. Dougan SK, Kaser A, Blumberg RS. CD1 expression on antigen-presenting cells. Curr Top Microbiol Immunol. 2007;314:113-41.


    CD_NAME : CD1b

    CD1b, as other members of the CD1 family, is involved in the immune response by presenting self and non-self lipid and glycolipid antigens to T cells.1 CD1b participates in the presentation of sulfoglycolipids of Mycobacterium tuberculosis and wall polimers of Corynebacterium, Rhodococcus and Mycobacterium.1

    1. Kaczmarek R, Pasciak M, Szymczak-Kulus K, Czerwinski M. CD1: A Singed Cat of the Three Antigen Presentation Systems. Arch Immunol Ther Exp (Warsz). 2017;65:201-214.


    CD_NAME : CD1b

    Cell marker

    CD1b tetramers loaded with sulfoglycolipids can be used to identify sulfoglycolipid-specific T cells.1

    1. James CA, Yu KKQ, Gilleron M, Prandi J, Yedulla VR, Moleda ZZ, Diamanti E, Khan M, Aggarwal VK, Reijneveld JF, Reinink P, Lenz S, Emerson RO, Scriba TJ, Souter MNT, Godfrey DI, Pellicci DG, Moody DB, Minnaard AJ, Seshadri C, Van Rhijn I. CD1b Tetramers Identify T Cells that Recognize Natural and Synthetic Diacylated Sulfoglycolipids from Mycobacterium tuberculosis. Cell Chem Biol. 2018. pii: S2451-9456(8)30006-0.



    To our knowledge, no therapy targeting CD1b has been approved. Nevertheless, an antibody fragment that recognizes CD1b associated with a Mycobacterium tuberculosis glycolipid has been obtained recently.1 This fragment opens the possibility for future therapeutic studies on Mycobacterium tuberculosis. In addition, a vaccine with Mycobacterium tuberculosis lipids, which are ligands of CD1b, was able to induce protection against infection in a guinea pig model.2

    1. Camacho F, Sarmiento ME, Reyes F, Kim L, Huggett J, Lepore M, Otero O, Gilleron M, Puzo G, Norazmi MN, Rook G, Mori L, De Libero G, Acosta A. Selection of phage-displayed human antibody fragments specific for CD1b presenting the Mycobacterium tuberculosis glycolipid Ac2SGL. Int J Mycobacteriol. 2016;5:120-7.
    2. Larrouy-Maumus G, Layre E, Clark S, Prandi J, Rayner E, Lepore M, de Libero G,  Williams A, Puzo G, Gilleron M. Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis. Vaccine. 2017;35:1395-1402.


    CD_NAME : CD1b


    DESC CD1B antigen; b polypeptide


    HGNC_LOCUS_TAG: 1635
    NCBI_MAP: 1q22-q23
    GENE_SIZE: 3480
    PRCORENC: 46 to 1047
    ENTREN: ENST00000368168
    NCBI_REF_SEF_ENTRY: NP_001755 , 4502645
    PR_MO_WEIGHT: 36939
    PR_SW_PR: 5.88
    IPI_NUMBER: IPI00019849
    ENSM_NUMBER: P29016

HCDM Sponsors: